<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="result" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="antithesis" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">3. Discussion</segment>
<segment id="2" parent="1004" relname="span">While most nAChR agonists and antagonists</segment>
<segment id="3" parent="2" relname="elaboration">binding at ACh orthosteric sites</segment>
<segment id="4" parent="1003" relname="same_unit">are basic molecules with at least one ionizable N ,</segment>
<segment id="5" parent="1005" relname="span">there are exceptions ,</segment>
<segment id="6" parent="5" relname="elaboration">including lophotoxin , the neonicotinoids and some recently synthesized pyrimidine agonists .</segment>
<segment id="7" parent="1007" relname="span">To optimize a molecule</segment>
<segment id="8" parent="7" relname="purpose">to serve as a drug or selective molecular probe of some receptor</segment>
<segment id="9" parent="1009" relname="span">it is important to identify the form</segment>
<segment id="10" parent="9" relname="elaboration">in which it interacts optimally with its target .</segment>
<segment id="11" parent="1013" relname="span">In the case of anabaseine , our identification of the cyclic iminium form as the most active</segment>
<segment id="12" parent="11" relname="elaboration">( and possibly the only ) form</segment>
<segment id="13" parent="1012" relname="same_unit">suggests</segment>
<segment id="14" parent="1014" relname="span">that structural modifications</segment>
<segment id="15" parent="14" relname="elaboration">that enhance the basicity of its tetrahydropyridyl nitrogen will enhance potency and possibly selectivity for the intended receptor target .</segment>
<segment id="16" parent="1016" relname="span">In fact , a major improvement in stability occurs with addition at the 3-position of the tetrahydropyridyl ring of an electron-conjugated system</segment>
<segment id="17" parent="1017" relname="joint">containing an aromatic ring , as in 3-(4-dimethylaminobenzylidene)-anabaseine or 3-(2,4-dimethoxybenzylidene)-anabaseine ,</segment>
<segment id="18" parent="1017" relname="joint">also called GTS-21 .</segment>
<segment id="19" parent="1021" relname="span">These anabaseine derivatives do not undergo ring opening</segment>
<segment id="20" parent="19" relname="elaboration">( hydrolysis of the imine bond )</segment>
<segment id="21" parent="1020" relname="same_unit">under physiological conditions ,</segment>
<segment id="22" parent="1019" relname="span">due to their extended π electron conjugation .</segment>
<segment id="23" parent="1024" relname="span">Previously , it was assumed</segment>
<segment id="24" parent="23" relname="elaboration">( but not experimentally tested )</segment>
<segment id="25" parent="1025" relname="span">that the cyclic iminium form of anabaseine is the one</segment>
<segment id="26" parent="25" relname="elaboration">which binds avidly to the ACh binding site in nAChRs .</segment>
<segment id="27" parent="1027" relname="span">This form was modeled</segment>
<segment id="28" parent="27" relname="purpose">to fit into a muscle type homology model .</segment>
<segment id="29" parent="1029" relname="span">The crystal structure of the molluscan acetylcholine binding protein</segment>
<segment id="30" parent="1030" relname="span">binding anabaseine actually was derived from crystals</segment>
<segment id="31" parent="1031" relname="span">containing both the cyclic iminium and the open-chain monocationic form of anabaseine</segment>
<segment id="32" parent="31" relname="elaboration">occupying some of the five identical binding sites .</segment>
<segment id="33" parent="1033" relname="preparation">Unlike the cyclic iminium , the ammonium-ketone form ammonium group did not insert into the “ aromatic box . ”</segment>
<segment id="34" parent="1034" relname="span">In the preparation of the AChBP-anabaseine crystals very high anabaseine concentrations were used</segment>
<segment id="35" parent="1035" relname="span">so that most of the five sites would be occupied ;</segment>
<segment id="36" parent="1037" relname="attribution">therefore the presence of the ammonium-ketone form in the crystal structure does not necessarily indicate</segment>
<segment id="37" parent="1037" relname="span">that this form of anabaseine would bind to AChBPs and nAChRs at the low concentrations of anabaseine</segment>
<segment id="38" parent="37" relname="elaboration">that occur in our in vitro functional and binding studies .</segment>
<segment id="39" parent="1039" relname="span">The ability of a variety of 2-(aryl)-1,4,5,6-tetrahydropyrmidines</segment>
<segment id="40" parent="39" relname="purpose">to block neuromuscular nAChRs and produce teratogenic effects in chick embryos was reported long ago .</segment>
<segment id="41" parent="1040" relname="joint">Some of these compounds were reported to be nAChR agonists .</segment>
<segment id="42" parent="1041" relname="joint">The only study of PTHP on neurons was that of Upshall et al. on leech Retzius cells .</segment>
<segment id="43" parent="44" relname="attribution">Our results also indicate</segment>
<segment id="44" parent="1043" relname="span">that PTHP is a potent agonist at neuronal as well as neuromuscular nAChRs .</segment>
<segment id="45" parent="1045" relname="span">The 2-aryl compounds</segment>
<segment id="46" parent="1046" relname="span">reported in the Brimblecombe et al. study did not include PTHP or other compounds</segment>
<segment id="47" parent="1047" relname="span">having a 2-(3-pyridyl)- substituent ,</segment>
<segment id="48" parent="47" relname="elaboration">which is known to be essential for the agonist activity of nicotine and of anabaseine .</segment>
<segment id="49" parent="1049" relname="span">For PTHP to be equipotent with anabaseine ,</segment>
<segment id="50" parent="1050" relname="span">based on the I+ form being the only active form ,</segment>
<segment id="51" parent="1051" relname="span">its EC50 would need to be ~1/3 of the EC50 of anabaseine ,</segment>
<segment id="52" parent="1053" relname="span">since the anabaseine</segment>
<segment id="53" parent="52" relname="restatement">( I+ )</segment>
<segment id="54" parent="1052" relname="same_unit">is ~1/3 of its total concentration .</segment>
<segment id="55" parent="1054" relname="joint">The data for PTHP and anabaseine in</segment>
<segment id="56" parent="1056" relname="joint">Figure 3</segment>
<segment id="57" parent="1056" relname="joint">and</segment>
<segment id="58" parent="1057" relname="joint">Figure 4</segment>
<segment id="59" parent="1060" relname="attribution">and in Table 1 , indicate</segment>
<segment id="60" parent="1060" relname="span">that PTHP has approximately 30 % of the potency</segment>
<segment id="61" parent="60" relname="elaboration">predicted for the anabaseine cyclic iminium form .</segment>
<segment id="62" parent="1062" relname="joint">One possible explanation for this slightly inferior potency is that the additional N on the tetrahydropyrmidinyl ring must form an H bond with some other atom within the aromatic box of the nAChR orthosteric binding site</segment>
<segment id="63" parent="1062" relname="joint">and this may be energetically unfavorable .</segment>
<segment id="64" parent="1065" relname="span">While 2,3′-bipyridyl displayed only a marginal potency at vertebrate receptors</segment>
<segment id="65" parent="64" relname="elaboration">that could be predicted from its pKa ,</segment>
<segment id="66" parent="1064" relname="span">it has been found to be quite paralytic to insects and crustaceans .</segment>
<segment id="67" parent="1068" relname="joint">At least some arthropod nAChRs are known to not require a cationic ligand for activation ,</segment>
<segment id="68" parent="1068" relname="joint">as shown by many studies with neonicotinoid insecticides such as imidachloprid .</segment>
<segment id="69" parent="1069" relname="span">These neonicotinoids also display a limited activity at vertebrate nAChRs .</segment>
<segment id="70" parent="71" relname="attribution">It seems likely</segment>
<segment id="71" parent="1070" relname="span">that 2,3′-bipyridyl affects some arthropod nAChRs through its unionized form .</segment>
<segment id="72" parent="1073" relname="attribution">One can speculate</segment>
<segment id="73" parent="1073" relname="span">as to what advantage(s) might accrue to an organism</segment>
<segment id="74" parent="1074" relname="span">( in this case , a hoplonemertine or ant )</segment>
<segment id="75" parent="74" relname="purpose">to produce and secrete an imine-bond containing toxin like anabaseine .</segment>
<segment id="76" parent="1075" relname="joint">The entire body wall integument as well as the contiguous epithelium of the anterior proboscis of P. peregrina contains very high concentrations of anabaseine .</segment>
<segment id="77" parent="1077" relname="joint">The proboscis everts</segment>
<segment id="78" parent="1078" relname="span">and wraps around the prey during its capture</segment>
<segment id="79" parent="78" relname="elaboration">allowing extensive contact of this epithelium with its annelid prey .</segment>
<segment id="80" parent="1080" relname="span">The mineralized stylet of the proboscis can be observed</segment>
<segment id="81" parent="1081" relname="span">to produce multiple punctures of the prey integument ,</segment>
<segment id="82" parent="81" relname="elaboration">which should further facilitate envenomation .</segment>
<segment id="83" parent="1082" relname="joint">In addition , potential predators will also be exposed in these ways to anabaseine and related alkaloids .</segment>
<segment id="84" parent="1084" relname="same_unit">Perhaps a major advantage of possessing an imine bond , besides an enhanced affinity for the nAChR orthosteric site ,</segment>
<segment id="85" parent="1085" relname="span">is its low basicity ,</segment>
<segment id="86" parent="1086" relname="span">which allows the unionized form to reach a relatively high concentration in the neutral pH range of the marine environment</segment>
<segment id="87" parent="86" relname="result">and thereby enhance passive diffusion across the integument of the prey or predator .</segment>
<segment id="88" parent="1089" relname="span">The integument of a marine organism</segment>
<segment id="89" parent="88" relname="elaboration">exposed to sea water</segment>
<segment id="90" parent="1090" relname="span">is likely to have a pH near 8 , well above the pH range</segment>
<segment id="91" parent="90" relname="elaboration">in which anabaseine is primarily ionized .</segment>
<segment id="92" parent="1092" relname="span">Thus , the toxin has a much better chance</segment>
<segment id="93" parent="92" relname="elaboration">of entering the prey/predator</segment>
<segment id="94" parent="1092" relname="antithesis">than would anabaseine , the more basic secondary amine analog of anabaseine .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="span"/>
<group id="1003" type="multinuc" parent="1005" relname="concession"/>
<group id="1004" type="span" parent="1003" relname="same_unit"/>
<group id="1005" type="span" parent="1002" relname="span"/>
<group id="1006" type="multinuc" parent="1002" relname="purpose"/>
<group id="1007" type="span" parent="1006" relname="joint"/>
<group id="1008" type="multinuc" parent="1006" relname="joint"/>
<group id="1009" type="span" parent="1008" relname="joint"/>
<group id="1010" type="multinuc" parent="1008" relname="joint"/>
<group id="1011" type="multinuc" parent="1010" relname="joint"/>
<group id="1012" type="multinuc" parent="1011" relname="same_unit"/>
<group id="1013" type="span" parent="1012" relname="same_unit"/>
<group id="1014" type="span" parent="1011" relname="same_unit"/>
<group id="1015" type="multinuc" parent="1010" relname="joint"/>
<group id="1016" type="span" parent="1015" relname="joint"/>
<group id="1017" type="multinuc" parent="16" relname="elaboration"/>
<group id="1018" type="multinuc" parent="1015" relname="joint"/>
<group id="1019" type="span" parent="1018" relname="joint"/>
<group id="1020" type="multinuc" parent="22" relname="concession"/>
<group id="1021" type="span" parent="1020" relname="same_unit"/>
<group id="1022" type="multinuc" parent="1018" relname="joint"/>
<group id="1023" type="multinuc" parent="1022" relname="joint"/>
<group id="1024" type="span" parent="1023" relname="same_unit"/>
<group id="1025" type="span" parent="1023" relname="same_unit"/>
<group id="1026" type="multinuc" parent="1022" relname="joint"/>
<group id="1027" type="span" parent="1026" relname="joint"/>
<group id="1028" type="multinuc" parent="1026" relname="joint"/>
<group id="1029" type="span" parent="1028" relname="joint"/>
<group id="1030" type="span" parent="29" relname="elaboration"/>
<group id="1031" type="span" parent="30" relname="elaboration"/>
<group id="1032" type="span" parent="1028" relname="joint"/>
<group id="1033" type="multinuc" parent="1032" relname="span"/>
<group id="1034" type="span" parent="1033" relname="joint"/>
<group id="1035" type="span" parent="34" relname="purpose"/>
<group id="1036" type="span" parent="35" relname="elaboration"/>
<group id="1037" type="span" parent="1036" relname="span"/>
<group id="1038" type="span" parent="1033" relname="joint"/>
<group id="1039" type="span" parent="1040" relname="preparation"/>
<group id="1040" type="multinuc" parent="1038" relname="span"/>
<group id="1041" type="multinuc" parent="1040" relname="joint"/>
<group id="1042" type="multinuc" parent="1041" relname="joint"/>
<group id="1043" type="span" parent="1042" relname="joint"/>
<group id="1044" type="multinuc" parent="1042" relname="joint"/>
<group id="1045" type="span" parent="1044" relname="joint"/>
<group id="1046" type="span" parent="45" relname="elaboration"/>
<group id="1047" type="span" parent="46" relname="elaboration"/>
<group id="1048" type="multinuc" parent="1044" relname="joint"/>
<group id="1049" type="span" parent="1048" relname="joint"/>
<group id="1050" type="span" parent="49" relname="elaboration"/>
<group id="1051" type="span" parent="50" relname="elaboration"/>
<group id="1052" type="multinuc" parent="51" relname="circumstance"/>
<group id="1053" type="span" parent="1052" relname="same_unit"/>
<group id="1054" type="multinuc" parent="1048" relname="joint"/>
<group id="1055" type="span" parent="1054" relname="joint"/>
<group id="1056" type="multinuc" parent="1057" relname="preparation"/>
<group id="1057" type="multinuc" parent="1055" relname="span"/>
<group id="1058" type="multinuc" parent="1057" relname="joint"/>
<group id="1059" type="span" parent="1058" relname="joint"/>
<group id="1060" type="span" parent="1059" relname="span"/>
<group id="1061" type="multinuc" parent="1058" relname="joint"/>
<group id="1062" type="multinuc" parent="1061" relname="joint"/>
<group id="1063" type="multinuc" parent="1061" relname="joint"/>
<group id="1064" type="span" parent="1063" relname="joint"/>
<group id="1065" type="span" parent="66" relname="condition"/>
<group id="1066" type="multinuc" parent="1063" relname="joint"/>
<group id="1067" type="span" parent="1066" relname="joint"/>
<group id="1068" type="multinuc" parent="1067" relname="span"/>
<group id="1069" type="span" parent="1068" relname="elaboration"/>
<group id="1070" type="span" parent="69" relname="elaboration"/>
<group id="1071" type="multinuc" parent="1066" relname="joint"/>
<group id="1072" type="span" parent="1071" relname="joint"/>
<group id="1073" type="span" parent="1072" relname="span"/>
<group id="1074" type="span" parent="73" relname="elaboration"/>
<group id="1075" type="multinuc" parent="1071" relname="joint"/>
<group id="1076" type="multinuc" parent="1075" relname="joint"/>
<group id="1077" type="multinuc" parent="1076" relname="joint"/>
<group id="1078" type="span" parent="1077" relname="joint"/>
<group id="1079" type="multinuc" parent="1076" relname="joint"/>
<group id="1080" type="span" parent="1079" relname="joint"/>
<group id="1081" type="span" parent="80" relname="purpose"/>
<group id="1082" type="multinuc" parent="1079" relname="joint"/>
<group id="1083" type="multinuc" parent="1082" relname="joint"/>
<group id="1084" type="multinuc" parent="1083" relname="sequence"/>
<group id="1085" type="span" parent="1084" relname="same_unit"/>
<group id="1086" type="span" parent="85" relname="elaboration"/>
<group id="1087" type="multinuc" parent="1083" relname="sequence"/>
<group id="1088" type="multinuc" parent="1087" relname="joint"/>
<group id="1089" type="span" parent="1088" relname="same_unit"/>
<group id="1090" type="span" parent="1088" relname="same_unit"/>
<group id="1091" type="span" parent="1087" relname="joint"/>
<group id="1092" type="span" parent="1091" relname="span"/>
	</body>
</rst>
